Ambu A/S (AMBBY)
USD 14.18
(0.0%)
USD 14.18
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 584 Million DKK | -68.35% |
| 2022 | 1.84 Billion DKK | 124.18% |
| 2021 | 823 Million DKK | -43.01% |
| 2020 | 1.44 Billion DKK | 25.02% |
| 2019 | 1.15 Billion DKK | -11.7% |
| 2018 | 1.3 Billion DKK | 66.41% |
| 2017 | 786 Million DKK | -20.61% |
| 2016 | 990 Million DKK | 27.09% |
| 2015 | 779 Million DKK | -5.58% |
| 2014 | 825 Million DKK | 6.45% |
| 2013 | 775 Million DKK | 745.33% |
| 2012 | 91.68 Million DKK | -21.06% |
| 2011 | 116.14 Million DKK | -2.18% |
| 2010 | 118.72 Million DKK | -2.91% |
| 2009 | 122.28 Million DKK | -3.23% |
| 2008 | 126.36 Million DKK | -13.55% |
| 2007 | 146.17 Million DKK | -14.67% |
| 2006 | 171.31 Million DKK | -37.15% |
| 2005 | 272.54 Million DKK | 52.78% |
| 2004 | 178.39 Million DKK | -11.72% |
| 2003 | 202.07 Million DKK | -10.45% |
| 2002 | 225.64 Million DKK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 612 Million DKK | -2.86% |
| 2024 Q2 | 630 Million DKK | 0.32% |
| 2024 Q1 | 628 Million DKK | 7.53% |
| 2023 Q3 | 744 Million DKK | -18.69% |
| 2023 Q1 | 1.94 Billion DKK | 5.26% |
| 2023 FY | 584 Million DKK | -68.35% |
| 2023 Q4 | 584 Million DKK | -21.51% |
| 2023 Q2 | 915 Million DKK | -52.88% |
| 2022 Q1 | 1.4 Billion DKK | 70.11% |
| 2022 Q3 | 1.54 Billion DKK | 1.31% |
| 2022 Q4 | 1.84 Billion DKK | 19.11% |
| 2022 FY | 1.84 Billion DKK | 124.18% |
| 2022 Q2 | 1.52 Billion DKK | 9.21% |
| 2021 Q1 | 1.87 Billion DKK | 29.78% |
| 2021 Q3 | 764 Million DKK | 25.04% |
| 2021 FY | 823 Million DKK | -43.01% |
| 2021 Q2 | 611 Million DKK | -67.4% |
| 2021 Q4 | 823 Million DKK | 7.72% |
| 2020 Q1 | 1.48 Billion DKK | 28.4% |
| 2020 FY | 1.44 Billion DKK | 25.02% |
| 2020 Q2 | 1.48 Billion DKK | 0.07% |
| 2020 Q4 | 1.44 Billion DKK | 8.33% |
| 2020 Q3 | 1.33 Billion DKK | -10.18% |
| 2019 Q4 | 1.15 Billion DKK | 1.49% |
| 2019 Q1 | 1.35 Billion DKK | 3.67% |
| 2019 Q2 | 1.31 Billion DKK | -3.24% |
| 2019 FY | 1.15 Billion DKK | -11.7% |
| 2019 Q3 | 1.13 Billion DKK | -13.26% |
| 2018 FY | 1.3 Billion DKK | 66.41% |
| 2018 Q1 | 1.04 Billion DKK | 32.7% |
| 2018 Q3 | 1.43 Billion DKK | 5.66% |
| 2018 Q4 | 1.3 Billion DKK | -8.98% |
| 2018 Q2 | 1.36 Billion DKK | 30.39% |
| 2017 Q3 | 954 Million DKK | -8.27% |
| 2017 FY | 786 Million DKK | -20.61% |
| 2017 Q1 | 1.13 Billion DKK | 14.95% |
| 2017 Q2 | 1.04 Billion DKK | -8.61% |
| 2017 Q4 | 786 Million DKK | -17.61% |
| 2016 Q1 | 952 Million DKK | 22.21% |
| 2016 Q2 | 1.05 Billion DKK | 10.61% |
| 2016 Q3 | 926 Million DKK | -12.06% |
| 2016 Q4 | 990 Million DKK | 6.91% |
| 2016 FY | 990 Million DKK | 27.09% |
| 2015 Q4 | 779 Million DKK | -11.88% |
| 2015 FY | 779 Million DKK | -5.58% |
| 2015 Q3 | 884 Million DKK | -6.06% |
| 2015 Q2 | 941 Million DKK | 2.62% |
| 2015 Q1 | 917 Million DKK | 11.15% |
| 2014 Q1 | 849 Million DKK | 9.55% |
| 2014 Q2 | 826 Million DKK | -2.71% |
| 2014 Q4 | 825 Million DKK | -7.2% |
| 2014 Q3 | 889 Million DKK | 7.63% |
| 2014 FY | 825 Million DKK | 6.45% |
| 2013 Q3 | 842.9 Million DKK | 9.35% |
| 2013 FY | 775 Million DKK | 745.33% |
| 2013 Q4 | 775 Million DKK | -8.06% |
| 2013 Q2 | 770.8 Million DKK | 0.0% |
| 2013 Q1 | - DKK | -100.0% |
| 2012 Q4 | 91.68 Million DKK | -40.43% |
| 2012 Q1 | 161.1 Million DKK | 38.71% |
| 2012 Q2 | 147.3 Million DKK | -8.57% |
| 2012 Q3 | 153.9 Million DKK | 4.48% |
| 2012 FY | 91.68 Million DKK | -21.06% |
| 2011 FY | 116.14 Million DKK | -2.18% |
| 2011 Q3 | 133.5 Million DKK | -0.67% |
| 2011 Q2 | 134.4 Million DKK | -16.42% |
| 2011 Q1 | 160.8 Million DKK | 35.44% |
| 2011 Q4 | 116.14 Million DKK | -13.0% |
| 2010 Q3 | 129 Million DKK | -7.33% |
| 2010 FY | 118.72 Million DKK | -2.91% |
| 2010 Q2 | 139.2 Million DKK | 0.0% |
| 2010 Q1 | - DKK | -100.0% |
| 2010 Q4 | 118.72 Million DKK | -7.96% |
| 2009 Q4 | 122.28 Million DKK | 0.0% |
| 2009 FY | 122.28 Million DKK | -3.23% |
| 2008 FY | 126.36 Million DKK | -13.55% |
| 2007 FY | 146.17 Million DKK | -14.67% |
| 2006 FY | 171.31 Million DKK | -37.15% |
| 2005 FY | 272.54 Million DKK | 52.78% |
| 2004 FY | 178.39 Million DKK | -11.72% |
| 2003 FY | 202.07 Million DKK | -10.45% |
| 2002 FY | 225.64 Million DKK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | -129827.05% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | -973233.333% |
| Össur hf. | 467.73 Million USD | -24.858% |
| QHSLab, Inc. | 1.78 Million USD | -32680.407% |
| Wellstar International, Inc. | 51.36 Million USD | -1036.918% |
| Össur hf. | 467.73 Million USD | -24.858% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 524.71 Thousand USD | -111197.666% |
| Aurora Spine Corporation | 2.67 Million USD | -21768.073% |
| BrainsWay Ltd. | 471 Thousand USD | -123891.507% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 14.83 Million USD | -3837.635% |
| Hamilton Thorne Ltd. | 27.81 Million USD | -1999.9% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | -117547.296% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -327779.897% |
| Zecotek Photonics Inc. | 3.22 Million USD | -18026.187% |
| Avitar, Inc. | 5.26 Million USD | -10991.642% |
| Nanomix Corporation | 11.4 Million USD | -5019.993% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | -11091.97% |
| Theraclion SA | 1.95 Million EUR | -29837.418% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.78 Million USD | -32570.726% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | -34282.348% |
| Lombard Medical, Inc. | 32.29 Million USD | -1708.497% |
| ALR Technologies Inc. | 19.26 Million USD | -2931.535% |
| Stratec SE | 156.16 Million USD | -273.962% |
| Vycor Medical, Inc. | 1.11 Million USD | -52500.86% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -278945.321% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 65.612% |
| VMS Rehab Systems, Inc. | 133.52 USD | -437387557.28% |
| NewCardio, Inc. | 3 Million USD | -19366.667% |
| Guided Therapeutics, Inc. | 2.05 Million USD | -28277.079% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | -92428.483% |
| Odyssey Group International, Inc. | 2.14 Million USD | -27130.423% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | -87064.179% |
| Wellness Center USA, Inc. | 4.04 Million USD | -14348.354% |
| SANUWAVE Health, Inc. | 31.94 Million USD | -1728.199% |
| IR-Med Inc. | 161 Thousand USD | -362632.919% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -302656.955% |
| Polarean Imaging plc | 216.38 Thousand USD | -269789.318% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 3.17 Million USD | -18315.416% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -583900.0% |
| Capital Group Holdings, Inc. | 4944.00 USD | -11812197.735% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | -72931.13% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -257166.456% |
| Urologix, Inc. | 5.33 Million USD | -10850.684% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | -15145.339% |
| Nexeon MedSystems Inc. | 4.21 Million USD | -13754.592% |
| SS Innovations International, Inc. | 8.21 Million USD | -7006.053% |
| Qualis Innovations, Inc. | 9102.00 USD | -6416072.27% |
| Smith & Nephew plc | 3.07 Billion USD | 81.037% |
| NIOX Group Plc | 1.4 Million USD | -41605.349% |
| Fuse Medical, Inc. | 1.99 Million USD | -29192.829% |
| Broncus Holding Corporation | 2.35 Million USD | -24705.043% |
| Brain Scientific Inc. | 2.86 Million USD | -20294.729% |
| Pressure BioSciences, Inc. | 22.75 Million USD | -2466.089% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -1443943.321% |